Terms: = Sarcomas AND HEY1, CHF-2, 23462, ENSG00000164683, HESR1, CHF2, HESR-1, MGC1274, HRT-1, OAF1, HERP2 AND Diagnosis
17 results:
1. Small cell osteosarcoma versus fusion-driven round cell sarcomas of bone: retrospective clinical, radiological, pathological, and (epi)genetic comparison with clinical implications.
Hiemcke-Jiwa LS; Sumathi VP; Baumhoer D; Smetsers SE; Haveman LM; van Noesel MM; van Langevelde K; Cleven AHG; van de Sande MAJ; Ter Horst SAJ; Kester LA; Flucke U
Virchows Arch; 2024 Mar; 484(3):451-463. PubMed ID: 38332052
[TBL] [Abstract] [Full Text] [Related]
2. Detection of mesenchymal chondrosarcoma in pleural effusion with immunocytochemistry and determination of hey1::NCOA2 fusion by next-generation sequencing on cell block.
Zhong J; Wang Q; Xie Y; Niu Z; Zhou D
Cytopathology; 2024 Jan; 35(1):149-152. PubMed ID: 37688410
[TBL] [Abstract] [Full Text] [Related]
3. NKX3.1 immunohistochemistry and methylome profiling in mesenchymal chondrosarcoma: additional diagnostic value for a well-defined disease?
Glauser S; Ameline B; Andrei V; Harder D; Pauli C; Trautmann M; Hartmann W; Baumhoer D
Pathology; 2023 Aug; 55(5):621-628. PubMed ID: 37225644
[TBL] [Abstract] [Full Text] [Related]
4. Construction of a transcription factor-miRNA-mRNA interactive network elucidates underlying pathogenesis for osteosarcoma and validation by qRT-PCR.
Tang F; Jiang X; Liao S; Liu Y; He M
Medicine (Baltimore); 2022 Oct; 101(41):e31049. PubMed ID: 36254052
[TBL] [Abstract] [Full Text] [Related]
5. A mesenchymal chondrosarcoma with aberrant nuclear expression of STAT6: a potential diagnostic pitfall.
Broggi G; Mazzucchelli M; Covello R; Casini B; Barbagallo GMV; Salvatorelli L; Magro G
Pathol Res Pract; 2022 Apr; 232():153803. PubMed ID: 35217266
[TBL] [Abstract] [Full Text] [Related]
6. [Extraskeletal mesenchymal chondrosarcoma in central nerve system: a clinicopathological analysis].
Wang YJ; Wang LM; Meng YH; Qi CH; Zhao LH; Lu DH; Teng LH
Zhonghua Bing Li Xue Za Zhi; 2021 Oct; 50(10):1157-1162. PubMed ID: 34619870
[No Abstract] [Full Text] [Related]
7. NKX3.1 immunohistochemistry is highly specific for the diagnosis of mesenchymal chondrosarcomas: experience in the Australian population.
Ramanayake N; Vargas AC; Talbot J; Bonar F; Wong DD; Wong D; Mahar A; Karim R; Luk PP; Selinger C; Sioson L; Gill AJ; Maclean F
Pathology; 2021 Oct; 53(6):705-712. PubMed ID: 33640159
[TBL] [Abstract] [Full Text] [Related]
8. NKX3.1 immunoreactivity is not identified in mesenchymal chondrosarcoma: a 25-case cohort study.
Chen W; Hornick JL; Fletcher CDM
Histopathology; 2021 Jan; 78(2):334-337. PubMed ID: 32779239
[TBL] [Abstract] [Full Text] [Related]
9. Primary intradural extramedullary spinal mesenchymal chondrosarcoma: case report and literature review.
Chen CW; Chen IH; Hu MH; Lee JC; Huang HY; Hong RL; Yang SH
BMC Musculoskelet Disord; 2019 Sep; 20(1):408. PubMed ID: 31484514
[TBL] [Abstract] [Full Text] [Related]
10. Detecting disease-defining gene fusions in unclassified round cell sarcomas using anchored multiplex PCR/targeted RNA next-generation sequencing-Molecular and clinicopathological characterization of 16 cases.
Mantilla JG; Ricciotti RW; Chen E; Hoch BL; Liu YJ
Genes Chromosomes Cancer; 2019 Oct; 58(10):713-722. PubMed ID: 31033080
[TBL] [Abstract] [Full Text] [Related]
11. An update of molecular pathology of bone tumors. Lessons learned from investigating samples by next generation sequencing.
Baumhoer D; Amary F; Flanagan AM
Genes Chromosomes Cancer; 2019 Feb; 58(2):88-99. PubMed ID: 30582658
[TBL] [Abstract] [Full Text] [Related]
12. Minute mesenchymal chondrosarcoma within osteochondroma: an unexpected diagnosis confirmed by hey1-NCOA2 fusion.
Toki S; Motoi T; Miyake M; Kobayashi E; Kawai A; Yoshida A
Hum Pathol; 2018 Nov; 81():255-260. PubMed ID: 29596896
[TBL] [Abstract] [Full Text] [Related]
13. Mesenchymal chondrosarcomas showing immunohistochemical evidence of rhabdomyoblastic differentiation: a potential diagnostic pitfall.
Folpe AL; Graham RP; Martinez A; Schembri-Wismayer D; Boland J; Fritchie KJ
Hum Pathol; 2018 Jul; 77():28-34. PubMed ID: 29559236
[TBL] [Abstract] [Full Text] [Related]
14. Integrating Morphology and Genetics in the diagnosis of Cartilage Tumors.
de Andrea CE; San-Julian M; Bovée JVMG
Surg Pathol Clin; 2017 Sep; 10(3):537-552. PubMed ID: 28797501
[TBL] [Abstract] [Full Text] [Related]
15. Pancreatic involvement by mesenchymal chondrosarcoma harboring the hey1-NCOA2 gene fusion.
Cohen JN; Solomon DA; Horvai AE; Kakar S
Hum Pathol; 2016 Dec; 58():35-40. PubMed ID: 27544802
[TBL] [Abstract] [Full Text] [Related]
16. Detection of hey1-NCOA2 fusion by fluorescence in-situ hybridization in formalin-fixed paraffin-embedded tissues as a possible diagnostic tool for mesenchymal chondrosarcoma.
Nakayama R; Miura Y; Ogino J; Susa M; Watanabe I; Horiuchi K; Anazawa U; Toyama Y; Morioka H; Mukai M; Hasegawa T
Pathol Int; 2012 Dec; 62(12):823-6. PubMed ID: 23252872
[TBL] [Abstract] [Full Text] [Related]
17. Identification of a novel, recurrent hey1-NCOA2 fusion in mesenchymal chondrosarcoma based on a genome-wide screen of exon-level expression data.
Wang L; Motoi T; Khanin R; Olshen A; Mertens F; Bridge J; Dal Cin P; Antonescu CR; Singer S; Hameed M; Bovee JV; Hogendoorn PC; Socci N; Ladanyi M
Genes Chromosomes Cancer; 2012 Feb; 51(2):127-39. PubMed ID: 22034177
[TBL] [Abstract] [Full Text] [Related]
